1. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol.,2006
2. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings;Cohen;Support Care Cancer.,2007
3. Co-administration of ondansetron and casopitant mesylate, a novel NK-1 receptor antagonist, results in augmented anti-emetic activity in the ferret [abstract];Gagnon;Proc Am Soc Clin Oncol.,2006
4. Evaluation of the NK-1 receptor antagonist, GW679769, in cisplatin-induced acute and delayed emesis in the ferret [abstract];King;Support Care Cancer.,2005
5. Chung F, Singla N, Singla S, Grenier A, Russo M. Casopitant for preventing postoperative vomiting in patients receiving opioids: pooled data analysis [abstract]. Paper presented at: 57th Annual Meeting of the American Society of Anesthesiologists; Madrid, Spain; October 13-17, 2006. Abstract A206.